• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 MARATHON; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 MARATHON; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number UNK-NV-MARATHON
Device Problem Difficult to Remove (1528)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Rasmus h.Dahl, markus holtmannspotter, henrik gutte, marie cortsen, john hauerberg, goetz benndorf.Snaring of a glued microcatheter during embolization of an arteriovenous malformation with n-butyl cyanoacrylate.Doi:10.1016/j.Wneu.2018.08.120 medtronic literature review found a report of a patient complication during the use of marathon.A (b)(6) woman presented because of headaches and vomiting for 11 days.She initially underwent diagnostic computed tomography, and a large intraventricular hemorrhage was found.Computed tomographic angiography and digital subtraction angiography revealed a right choroidal avm (spetzler-martin grade 4) with deep venous drainage and a prenidal aneurysm arising from the distal anterior choroidal artery (acha).The aneurysm was considered the acute bleeding source, and the patient elected to proceed with coil occlusion to be followed by staged nidus embolization.A marathon microcatheter (medtronic, minneapolis, minnesota, usa) was navigated distally to embolize a posterior nidus compartment using acrylic glue.A mixture of 33% nbca (glubran, gem srl, viareggio, italy) and 67% ethiodized oil (lipiodol, guerbet, aulnay-sous-bois, france) was prepared, and 0.2mlof the nbcamixture was injected under biplane subtracted fluoroscopy (blank road map).During this injection, reflux occurred earlier than expected and before relevant nidus penetration and glued the catheter tip rapidly into the distal feeder.Immediate attempts to carefully withdraw the microcatheter by simple pulling of its proximal end failed.Because leaving the microcatheter in the acha was considered exposing the patient to a significant risk of thromboembolic complications in a sensitive territory, endovascular catheter removal was discussed in our team and then performed.First, a buddy-catheter technique 10 using a second microcatheter (headway duo, microvention) that was advanced in parallel to the marathon into the distal acha was attempted but failed to free the glued microcatheter.Therefore, the hub of the marathon microcatheter was cut off allowing for removal of the sofia 55 catheter.Then, a 2-mm amplatz goose-neck microsnare (medtronic) was slid over the end of the entrapped microcatheter and slowly advanced along this catheter to its distal end.This was supported by slightly pulling back the entrapped marathon to straighten the course of the acha.The snare was then tightened around the catheter¿s tip as closely as possible to the nbca cast.Repeated, gentle, and simultaneous pulling of both the trapped microcatheter and the snare was applied over approximately 10 minutes.Whereas it appeared not possible to grab the glue surrounding the catheter itself to break it off, repeated alternate pulling and relaxing the system eventually resulted in freeing and removal of the microcatheter.Immediate postprocedure digital subtraction angiography run showed no noticeable spasm, dissection, or extravasation.The patient woke up with no new deficits and had an uneventful postoperative course.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MARATHON
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
katcha taylor
9775 toledo way
irvine, CA 92618
9496801345
MDR Report Key9218382
MDR Text Key207608380
Report Number2029214-2019-01053
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
K093750
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 10/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNK-NV-MARATHON
Device Catalogue NumberUNK-NV-MARATHON
Device Lot NumberNOT-REP
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/02/2019
Initial Date FDA Received10/22/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-